J 2018

The Results of Neuroendoscopic Surgery in Patients with Posttraumatic and Posthemorrhagic Hydrocephalus

CHRASTINA, Jan, Zdeněk NOVÁK, Tomáš ZEMAN, Věra FEITOVÁ, Dušan HRABOVSKÝ et. al.

Základní údaje

Originální název

The Results of Neuroendoscopic Surgery in Patients with Posttraumatic and Posthemorrhagic Hydrocephalus

Autoři

CHRASTINA, Jan (203 Česká republika, garant, domácí), Zdeněk NOVÁK (203 Česká republika, domácí), Tomáš ZEMAN (203 Česká republika, domácí), Věra FEITOVÁ (203 Česká republika), Dušan HRABOVSKÝ (703 Slovensko, domácí) a Ivo ŘÍHA (203 Česká republika, domácí)

Vydání

WORLD NEUROSURGERY, NEW YORK, ELSEVIER SCIENCE INC, 2018, 1878-8750

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30210 Clinical neurology

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 1.723

Kód RIV

RIV/00216224:14110/18:00103955

Organizační jednotka

Lékařská fakulta

UT WoS

000432942700016

Klíčová slova anglicky

Endoscopic third ventriculostomy; Hydrodynamic theory; Neuroendoscopy; Posthemorrhagic hydrocephalus; Posttraumatic hydrocephalus

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 11. 2. 2019 14:19, Soňa Böhmová

Anotace

V originále

BACKGROUND: Posttraumatic hydrocephalus (PTH) and posthemorrhagic hydrocephalus (PHH) were previously considered not suitable for neuroendoscopic treatment. New hydrocephalus theories support possible successful neuroendoscopy in such patients. METHODS: This study presents the results of neuroendoscopy in PTH and PHH with a background analysis. From 130 hydrocephalic patients after neuroendoscopic surgeries, 35 cases with PTH (n = 11) or PHH (n = 24; acute: n = 9, subacute: n = 10, chronic: n = 5) were found. The success rate (Glasgow Outcome Scale [GOS] score 4 or 5 without shunt) and clinical outcome (GOS score) of endoscopic third ventriculostomy (ETV) were analyzed. During the study period, 34 patients had ventriculoperitoneal shunts implanted, including 2 PTH and 5 PHH patients (all chronic). RESULTS: The success rate of ETV in PTH was 54.5%. In acute PHH, the success rate was 33.3%, 42.8% after excluding devastating hematomas. A post-ETV shunt was implanted in 1 patient (massive subarachnoid hemorrhage [SAH]) with final GOS score of 5. In subacute cases, the ETV success rate was 40% (no post-ETV shunts). In chronic PHH, only 1 patient with a GOS score of 5 was shunt-free (20%). The cause of ETV failure was massive SAH. Low final GOS score was caused by the extent of intracerebral bleeding or extracranial problems. The main indications for primary shunt implantation in PTH and PHH were infectious complications. The rate of good outcomes was 0% in PTH and 40% in PHH. CONCLUSIONS: The best results of neuroendoscopy were achieved in PTH and acute PHH. ETV failures were associated with massive SAH; arachnoid cistern blockage and scarring precludes ETV success.